{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:12:36Z","timestamp":1762297956338},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.micpath.2013.02.003","type":"journal-article","created":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T10:33:53Z","timestamp":1360838033000},"page":"33-40","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Neisseria meningitidis serogroup B vaccine development"],"prefix":"10.1016","volume":"57","author":[{"given":"Nicole M.","family":"Caesar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth A.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2013.02.003_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1699-0463.1998.tb01379.x","article-title":"Population genetics and molecular epidemiology of Neisseria meningitidis","volume":"106","author":"Caugant","year":"1998","journal-title":"Apmis"},{"issue":"5","key":"10.1016\/j.micpath.2013.02.003_bib2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.meegid.2008.04.002","article-title":"Genetics and evolution of Neisseria meningitidis: importance for the epidemiology of meningococcal disease","volume":"8","author":"Caugant","year":"2008","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.micpath.2013.02.003_bib3","series-title":"Yellow book: meningococcal disease, emerging infections program network, Neisseria meningitidis","author":"Centers for Disease Control and Prevention","year":"2012"},{"issue":"3","key":"10.1016\/j.micpath.2013.02.003_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11904-012-0127-7","article-title":"New insights in the prevention, diagnosis and treatment of Cryptococcal meningitis","volume":"9","author":"Jackson","year":"2012","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.micpath.2013.02.003_bib5","series-title":"Initiative for vaccine research (IVR)","author":"WHO","year":"2012"},{"key":"10.1016\/j.micpath.2013.02.003_bib6","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1056\/NEJMoa1005384","article-title":"Emerging infections programs network: bacterial meningitis in the United States, 1998-2007","volume":"364","author":"Thigpen","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micpath.2013.02.003_bib7","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3201\/eid0910.030182","article-title":"Environmental risk and meningitis epidemics in Africa","volume":"9","author":"Molesworth","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"2637","key":"10.1016\/j.micpath.2013.02.003_bib8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/bmj.281.6237.427","article-title":"Changing patterns of communicable disease in England and Wales. Part I: newly recognized diseases","volume":"281","author":"Galbraith","year":"1980","journal-title":"Br Med J"},{"issue":"Suppl. 8","key":"10.1016\/j.micpath.2013.02.003_bib9","first-page":"140","article-title":"Factor H and neisserial pathogenesis","volume":"26","author":"Welsch","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2013.02.003_bib10","series-title":"Microbiology a human perspective","author":"Nester","year":"2009"},{"issue":"9","key":"10.1016\/j.micpath.2013.02.003_bib11","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1128\/IAI.01377-09","article-title":"Transcellular passage of Neisseria meningitidis across a polarized respiratory epithelium","volume":"78","author":"Sutherland","year":"2010","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.micpath.2013.02.003_bib12","doi-asserted-by":"crossref","first-page":"e14034","DOI":"10.1371\/journal.pone.0014034","article-title":"Olfactory nerve\u2014a novel invasion route of Neisseria meningitidis to reach the meninges","volume":"5","author":"Sj\u00f6linder","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.micpath.2013.02.003_bib13","doi-asserted-by":"crossref","first-page":"e1001027","DOI":"10.1371\/journal.ppat.1001027","article-title":"The meningococcal vaccine candidate neisserial surface protein a (NspA) binds to factor H and enhances meningococcal resistance to complement","volume":"6","author":"Lewis","year":"2010","journal-title":"PLoS Pathog"},{"issue":"9","key":"10.1016\/j.micpath.2013.02.003_bib14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1042\/CS20090513","article-title":"Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease","volume":"118","author":"Hill","year":"2010","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.micpath.2013.02.003_bib15","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1073\/pnas.91.9.3769","article-title":"Roles of pilin and PilC in adhesion of Neisseria meningitidis to human epithelial and endothelial cells","volume":"91","author":"Nassif","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micpath.2013.02.003_bib16","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1365-2958.1995.mmi_17050855.x","article-title":"High adhesiveness of encapsulated Neisseria meningitidis to epithelial cells is associated with the formation of bundles of pili","volume":"17","author":"Marceau","year":"1995","journal-title":"Mol Microbiol"},{"issue":"29","key":"10.1016\/j.micpath.2013.02.003_bib17","first-page":"1","article-title":"Outer membrane biogenesis in E.\u00a0coli, Neisseria meningitidis, and Helicobacter pylori; paradigm deviations in H.\u00a0pylori","volume":"2","author":"Liechti","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.micpath.2013.02.003_bib18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2958.1993.tb00922.x","article-title":"Meningococcal Opa and Opc proteins: their role in colonization and invasion of human epithelial and endothelial cells","volume":"10","author":"Virji","year":"1993","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.micpath.2013.02.003_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2958.1994.tb00416.x","article-title":"Variable expression of the Opc outer membrane protein in Neisseria meningitidis is caused by size variation of a promoter containing polycitadine","volume":"13","author":"Sarkari","year":"1994","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.micpath.2013.02.003_bib20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1128\/CMR.19.1.142-164.2006","article-title":"Prospects for vaccine prevention of meningococcal infection","volume":"19","author":"Harrison","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.micpath.2013.02.003_bib21","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral immunity","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J\u00a0Exp Med"},{"issue":"3","key":"10.1016\/j.micpath.2013.02.003_bib22","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for the use meningococcal serogroup C conjugate vaccine in the United Kingdom: reevaluation of correlates of protection","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2013.02.003_bib23","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1016\/j.vaccine.2011.04.092","article-title":"Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2013.02.003_bib24","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/IAI.01191-08","article-title":"Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera","volume":"77","author":"Granoff","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2013.02.003_bib25","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1128\/IAI.00891-10","article-title":"Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies","volume":"79","author":"Seib","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2013.02.003_bib26","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1073\/pnas.0915162107","article-title":"Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans","volume":"107","author":"Serruto","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micpath.2013.02.003_bib27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1462-5822.2011.01722.x","article-title":"Human heat shock protein (Hsp) 90 interferes with Neisseria meningitidis adhesin a (Nad-A)-mediated adhesion and invasion","volume":"3","author":"Montanari","year":"2012","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.micpath.2013.02.003_bib28","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1084\/jem.20020407","article-title":"NadA, a novel vaccine candidate for Neisseria meningitidis","volume":"195","author":"Comanducci","year":"2002","journal-title":"J\u00a0Exp Med"},{"issue":"5","key":"10.1016\/j.micpath.2013.02.003_bib29","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1128\/IAI.65.12.5184-5190.1997","article-title":"Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal OMV vaccine","volume":"12","author":"van der Voort","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2013.02.003_bib30","doi-asserted-by":"crossref","first-page":"e1000710","DOI":"10.1371\/journal.ppat.1000710","article-title":"A\u00a0novel phase variation mechanism in the meningococcus driven by a ligand-responsive repressor and differential spacing of distal promoter elements","volume":"5","author":"Metruccio","year":"2009","journal-title":"PLoS Pathog"},{"issue":"48","key":"10.1016\/j.micpath.2013.02.003_bib31","doi-asserted-by":"crossref","first-page":"41767","DOI":"10.1074\/jbc.M111.289314","article-title":"Structure of the C-terminal domain of NHBA, on the main antigens of a novel vaccine against N.\u00a0meningitidis","volume":"286","author":"Esposito","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.micpath.2013.02.003_bib32","doi-asserted-by":"crossref","first-page":"B87","DOI":"10.1016\/j.vaccine.2012.01.033","article-title":"The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens","volume":"30","author":"Serruto","year":"2012","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.micpath.2013.02.003_bib33","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1046\/j.1365-2958.1999.01416.x","article-title":"Interactions of pathogenic Neisseria with host cells. Is it possible to assemble the puzzle?","volume":"32","author":"Nassif","year":"1999","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.micpath.2013.02.003_bib34","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1046\/j.1365-2958.1999.01230.x","article-title":"Mutagenesis of the Neisseria porin reduces invasion in epithelial cells and enhances phagocyte responsiveness","volume":"31","author":"Bauer","year":"1999","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.micpath.2013.02.003_bib35","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1002\/j.1460-2075.1995.tb07208.x","article-title":"Binding of syndecan like cell surface proteoglycan receptors is required for Neisseria gonorrheae entry into human mucosal cells","volume":"14","author":"van Putten","year":"1995","journal-title":"EMBO J"},{"key":"10.1016\/j.micpath.2013.02.003_bib36","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(12)70087-7","article-title":"Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomized, single-blind, placebo-controlled, phase 2 trial","volume":"12","author":"Richmond","year":"2012","journal-title":"Lancet"},{"issue":"Suppl. 2","key":"10.1016\/j.micpath.2013.02.003_bib37","doi-asserted-by":"crossref","first-page":"B71","DOI":"10.1016\/j.vaccine.2009.04.070","article-title":"Biology and pathogenesis of the evolutionary successful obligate human bacterium Neisseria meningitidis","volume":"27","author":"Stephens","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.micpath.2013.02.003_bib38","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/IAI.73.3.1491-1505.2005","article-title":"Translocation and surface expression of lipidated serogroup B capsular polysaccharide in Neisseria meningitidis","volume":"73","author":"Tzeng","year":"2005","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.micpath.2013.02.003_bib39","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1073\/pnas.86.5.1669","article-title":"Molecular characterization and expression in Escherichia coli of the gene complex encoding the polysaccharide capsule of Neisseria meningitidis group B","volume":"86","author":"Frosch","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micpath.2013.02.003_bib40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.yapd.2005.03.005","article-title":"Meningococcal infections at the start of the 21st century","volume":"52","author":"Brandtzaeg","year":"2005","journal-title":"Adv Pediatr"},{"key":"10.1016\/j.micpath.2013.02.003_bib41","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(11)61713-3","article-title":"Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b\/3 randomised, observer-blind, placebo-controlled study","volume":"379","author":"Santolaya","year":"2012","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.micpath.2013.02.003_bib42","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.1128\/IAI.71.12.6712-6720.2003","article-title":"Genetic basis for biosynthesis of the (Alpha1\u21924) linked N-acetyl-D-glucosamine-1-phosphate-capsule of the Neisseria meningitidis serogroup X","volume":"71","author":"Tzeng","year":"2003","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.micpath.2013.02.003_bib43","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pneurobio.2009.12.004","article-title":"Mechanisms of meningeal invasion by a bacterial extracellular pathogen, the example of Neisseria meningitidis","volume":"9","author":"Join-Lamber","year":"2010","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.micpath.2013.02.003_bib44","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1084\/jem.129.6.1349","article-title":"Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2013.02.003_bib45","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1016\/j.vaccine.2006.03.034","article-title":"A\u00a0review of vaccine research and development: meningococcal disease","volume":"24","author":"Girard","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2013.02.003_bib46","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(07)70210-4","article-title":"Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?","volume":"7","author":"O'Brien","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.micpath.2013.02.003_bib47","series-title":"International coordinating group (ICG) on vaccine provision for epidemic meningitis control. Report of seventh meeting. Geneva, Switzerland","first-page":"21","article-title":"Department of communicable disease surveillance and response","author":"World Health Organization","year":"2001"},{"issue":"Suppl. 1","key":"10.1016\/j.micpath.2013.02.003_bib48","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0264-410X(01)00299-7","article-title":"Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story","volume":"20","author":"Miller","year":"2001","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.micpath.2013.02.003_bib49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2165\/11204790-000000000-00000","article-title":"Meningococcal quadrivalent (serogroups A, C, W-135 and Y) conjugate vaccine (Menveo): in adolescents and adults","volume":"24","author":"Deeks","year":"2010","journal-title":"BioDrugs"},{"issue":"2","key":"10.1016\/j.micpath.2013.02.003_bib50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/0970-0218.96085","article-title":"Protein conjugate polysaccharide vaccines: challenges in development and global implementation","volume":"37","author":"Nair","year":"2012","journal-title":"Indian J Community Med"},{"issue":"Suppl. 1","key":"10.1016\/j.micpath.2013.02.003_bib51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0035-9203(91)90338-Y","article-title":"Meningococcal molecular mimicry and the search for an ideal vaccine","volume":"85","author":"Griffiss","year":"1991","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8346","key":"10.1016\/j.micpath.2013.02.003_bib52","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis: implications for vaccine development and pathogenesis","volume":"322","author":"Finne","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2013.02.003_bib53","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0264-410X(96)00001-1","article-title":"Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine","volume":"14","author":"Peeters","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2013.02.003_bib54","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1128\/CVI.00047-06","article-title":"Persisting immune responses indicating long-term protection after booster dose with meningococcal group B outer membrane vesicle vaccine","volume":"13","author":"Feiring","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.micpath.2013.02.003_bib55","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/adc.2007.132571","article-title":"Phase II meningococcal B vesicle vaccine trial in New Zealand infants","volume":"10","author":"Jackson","year":"2009","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.micpath.2013.02.003_bib56","doi-asserted-by":"crossref","first-page":"S293","DOI":"10.1097\/01.inf.0000147645.53942.00","article-title":"The strategy to control New Zealand's epidemic of group B meningococcal disease","volume":"23","author":"O'Hallahan","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.micpath.2013.02.003_bib57","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.vaccine.2005.01.063","article-title":"MeNZB: a safe\u00a0and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain","volume":"23","author":"Oster","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2013.02.003_bib58","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1016\/j.vaccine.2007.01.023","article-title":"Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand","volume":"25","author":"Oster","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2013.02.003_bib59","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4161\/hv.3.5.4458","article-title":"Post-marketing safety monitoring of a new group B meningococcal vaccine in New Zealand, 2004-2006","volume":"3","author":"McNicholas","year":"2007","journal-title":"Hum Vaccine"},{"issue":"1","key":"10.1016\/j.micpath.2013.02.003_bib60","doi-asserted-by":"crossref","first-page":"16","DOI":"10.37757\/MR2007V9.N1.6","article-title":"Cuban meningococcal BC vaccine: experiences and contribution from 20 years of application","volume":"9","author":"Padron","year":"2007","journal-title":"MEDICC Rev"},{"issue":"7","key":"10.1016\/j.micpath.2013.02.003_bib61","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1128\/IAI.70.7.3621-3626.2002","article-title":"Neisseria lactamica protects against experimental meningococcal infection","volume":"70","author":"Oliver","year":"2002","journal-title":"Infect Immun"},{"issue":"5459","key":"10.1016\/j.micpath.2013.02.003_bib62","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"issue":"17\u201319","key":"10.1016\/j.micpath.2013.02.003_bib63","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1016\/S0264-410X(00)00554-5","article-title":"Reverse vaccinology, a genome-based approach to vaccine development","volume":"19","author":"Rapuoli","year":"2001","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.micpath.2013.02.003_bib64","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nbt728","article-title":"Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarray","volume":"20","author":"Grifantini","year":"2002","journal-title":"Nat Biotechnol"},{"issue":"Suppl. 2","key":"10.1016\/j.micpath.2013.02.003_bib65","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2009.04.071","article-title":"Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis serogroup B","volume":"27","author":"Holst","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2013.02.003_bib66","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1128\/JCM.38.9.3323-3328.2000","article-title":"Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States: the active bacterial core surveillance team","volume":"38","author":"Tondella","year":"2000","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.micpath.2013.02.003_bib67","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1016\/j.vaccine.2006.03.091","article-title":"Neisseria meningitidis group B correlates of protection and assay standardization-international meeting report Emory University, Atlanta, Georgia, United States","volume":"24","author":"Borrow","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2013.02.003_bib68","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A\u00a0universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micpath.2013.02.003_bib69","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micpath.2013.02.003_bib70","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.vaccine.2009.02.098","article-title":"Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus","volume":"27","author":"Bambini","year":"2009","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.micpath.2013.02.003_bib71","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1128\/JCM.00936-09","article-title":"Characterisation of fHbp, NHBA (GNA2132), NadA, PorA, sequence type and the genomic presence of IS1301 in group B meningococcal ST269 clonal complex case-isolates from England and Wales","volume":"47","author":"Lucidarme","year":"2009","journal-title":"J\u00a0Clin Microbiol"},{"issue":"31","key":"10.1016\/j.micpath.2013.02.003_bib72","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1016\/j.vaccine.2010.05.014","article-title":"Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus","volume":"28","author":"Giuliani","year":"2010","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.micpath.2013.02.003_bib73","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.4049\/jimmunol.172.9.5606","article-title":"Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine","volume":"172","author":"Welsch","year":"2004","journal-title":"J\u00a0Immunol"},{"issue":"4585","key":"10.1016\/j.micpath.2013.02.003_bib74","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1126\/science.6337396","article-title":"Human insulin from recombinant DNA technology","volume":"219","author":"Johnson","year":"1983","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.micpath.2013.02.003_bib75","first-page":"573","article-title":"Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial","volume":"8","author":"Grossger","year":"2012","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.micpath.2013.02.003_bib76","unstructured":"Herper M. Who would have ever thought a vaccine to protect babies' brains could be a tough sell? Forbes Web http:\/\/www.forbes.com\/sites\/matthewherper\/2012\/02\/24\/who-would-have-ever-thought-a-vaccine-to-protect-babies-brains-could-be-a-tough-sell\/ [accessed 12\/2012]."},{"issue":"1\u20132","key":"10.1016\/j.micpath.2013.02.003_bib77","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2005.06.016","article-title":"Complement escape of human pathogenic bacteria y acquisition of complement regulators","volume":"43","author":"Kraiczy","year":"2006","journal-title":"Mol Immunol"},{"issue":"3","key":"10.1016\/j.micpath.2013.02.003_bib78","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1086\/600141","article-title":"Sequence diversity of vaccine candidate LP2086 in epidemiologically relevant strains of serogroup B Neisseria meningitidis","volume":"200","author":"Murphy","year":"2009","journal-title":"J\u00a0Infec Dis"},{"key":"10.1016\/j.micpath.2013.02.003_bib79","series-title":"Meningococcal vaccines","author":"Granoff","year":"2008"},{"issue":"4","key":"10.1016\/j.micpath.2013.02.003_bib80","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.micpath.2013.02.003_bib81","series-title":"Proceedings of the 13th international pathogenic neisseria conference. Oslo, Norway","first-page":"116","article-title":"Identification of a novel vaccine candidate for group B Neisseria meningitidis","author":"Bernfield","year":"2002"},{"key":"10.1016\/j.micpath.2013.02.003_bib82","series-title":"Neisseria meningitidis serogroup B vaccine: pre-meeting background document","author":"FDA Advisory Committee","year":"2011"},{"issue":"3","key":"10.1016\/j.micpath.2013.02.003_bib83","doi-asserted-by":"crossref","DOI":"10.4161\/hv.23222","article-title":"Potential impact of the bivalent Rlp2086 vaccine on Neisseria meningitidis invasive disease and carriage isolates in two adolescent populations","volume":"9","author":"Anderson","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.micpath.2013.02.003_bib84","doi-asserted-by":"crossref","first-page":"24825","DOI":"10.1074\/jbc.M302803200","article-title":"Crystal structure of Neisserial surface protein A (NspA), a conserved outer membrane protein with vaccine potential","volume":"278","author":"Vandeputte-Rutten","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"1\u20132","key":"10.1016\/j.micpath.2013.02.003_bib85","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0168-1656(00)00294-7","article-title":"Candidate Neisseria meningitidis NspA vaccine","volume":"83","author":"Martin","year":"2000","journal-title":"J\u00a0Biotechnol"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401013000235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401013000235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T14:44:36Z","timestamp":1688049876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401013000235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":85,"alternative-id":["S0882401013000235"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2013.02.003","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}